Foresee Pharmaceuticals Advances CPP Treatment as First Clinical Trial Recommended for Continuation Foresee Pharmaceuticals' Casppian Phase 3 study receives a positive recommendation to continue, showcasing innovative treatment for Central Precocious Puberty.

Foresee Pharmaceuticals Advances CPP Treatment as First Clinical Trial Recommended for Continuation #Taiwan #Taipei #Foresee_Pharmaceuticals #CPP_Treatment #Casppian_Study